ATR vs CRL · P/E 21, rev $2.01B vs rev $2.00B
AptarGroup Inc (ATR) versus Charles River Laboratories (CRL) — a side-by-side from cached financials, not a winner call.
AptarGroup Inc (ATR) is a medical instruments & supplies company listed on NYSE.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Latest reported ATR revenue for 2026-06-30 was $2.01B. Net income was $160.2M. ATR currently screens at market cap $7.66B and trailing P/E 20.5.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
ATR currently screens at market cap $7.66B and trailing P/E 20.5. CRL currently screens at market cap $7.78B.
Not investment advice. Open the ATR and CRL stock pages for the full models.
Not investment advice.